Document Detail

Early intravenous beta blockade and thrombolytics in acute myocardial infarction.
MedLine Citation:
PMID:  7904119     Owner:  NLM     Status:  MEDLINE    
This article discusses therapy with beta blockade and thrombolytic agents in acute myocardial infarction. In large and well-controlled studies both treatment strategies have been shown to increase survival. Both therapies have also been demonstrated to be safe in acute myocardial infarction. Historically, the 2 different treatment strategies have been tested during different time periods, resulting in few studies with the main objective to study the combined effects of the 2 agents. From the data that are presently available, however, there is a clear suggestion of additive beneficial effect and the 2 treatments given in combination are well tolerated.
G Olsson; P Held
Related Documents :
3592299 - Myocardial reperfusion by thrombolysis after acute total left main artery occlusion--a ...
1900139 - Pericardial effusion after intravenous recombinant tissue-type plasminogen activator fo...
1894539 - Clinical management of patients receiving thrombolytic therapy.
2507069 - Role of the general practitioner in managing patients with myocardial infarction: impac...
12182909 - Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute my...
1430679 - Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarctio...
18484159 - Prognostic value of coronary flow reserve and aortic distensibility indices in patients...
10374029 - Efficacy of contraction uncoupling by 2,3-butanedione monoxime during initial reperfusi...
22313569 - Acute st-elevation myocardial infarction in a 24-year-old woman with atheromatous coron...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of cardiology     Volume:  72     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  1993 Dec 
Date Detail:
Created Date:  1994-02-04     Completed Date:  1994-02-04     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  156G-160G     Citation Subset:  AIM; IM    
Cardiovascular Medicine, Astra Hässle AB, Mölndal, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Antagonists / therapeutic use*
Drug Therapy, Combination
Fibrinolytic Agents / therapeutic use*
Infusions, Intravenous
Myocardial Infarction / drug therapy*
Survival Analysis
Time Factors
Reg. No./Substance:
0/Adrenergic beta-Antagonists; 0/Fibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Studies on background of gamma-GTP abnormality in human multiphasic screening. (Part 3): Multiple re...
Next Document:  Combined enzymatic and linkage analysis for heterozygote detection in Hunter syndrome: identificatio...